Ozempic, a brand name for semaglutide, revolutionizes diabetes management with its unique approach. This injectable medication primarily targets the GLP-1 (glucagon-like peptide-1) receptor. When it binds to these receptors, Ozempic enhances insulin secretion in response to meals while suppressing glucagon release, which ultimately lowers blood sugar levels. It doesn’t just…